Evidence map›Paper›PMID 29314866›Full record

Trial reportJournal of alternative and complementary medicine (New York, N.Y.)2018

Spearmint Extract Improves Working Memory in Men and Women with Age-Associated Memory Impairment.

Kelli A Herrlinger, Kristin M Nieman, Kristen D Sanoshy, Brenda A Fonseca, Joanne A Lasrado, Arianne L Schild, Kevin C Maki, Keith A Wesnes, Michael A Ceddia

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of alternative and complementary medicine (New York, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 6 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 6 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Review
  12. Cognitive benefits of sleep: a narrative review to explore the relevance of glucose regulation.Sleep advances : a journal of the Sleep Research Society · 2025
    Review
  13. Review
  14. Promising benefits of six-monthFrontiers in aging · 2025
    Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 4 countries.

Kelli A Herrlinger1 Kemin Foods, LC , Des Moines, IA.
Kristin M Nieman2 Biofortis Research Services/Mérieux NutriSciences , Addison, IL.
Kristen D Sanoshy2 Biofortis Research Services/Mérieux NutriSciences , Addison, IL.
Brenda A Fonseca1 Kemin Foods, LC , Des Moines, IA.
Joanne A Lasrado1 Kemin Foods, LC , Des Moines, IA.
Arianne L Schild2 Biofortis Research Services/Mérieux NutriSciences , Addison, IL.
Kevin C Maki2 Biofortis Research Services/Mérieux NutriSciences , Addison, IL.
Keith A Wesnes3 Bracket, LLC , Wayne, PA.
Michael A Ceddia1 Kemin Foods, LC , Des Moines, IA.
Des Moines University · USInstitut Mérieux (France) · FRNorthumbria University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe purpose of this study was to investigate the effects of supplementation with a spearmint (Mentha spicata L.) extract, high in polyphenols including rosmarinic acid, on cognitive performance, sleep, and mood in individuals with age-associated memory impairment (AAMI).

designSubjects with AAMI (N = 90; 67% female; age = 59.4 ± 0.6 years) were randomly assigned (n = 30/group) to consume 900, 600, or 0 mg/day (two capsules, once daily) spearmint extract for 90 days, in this double-blind, placebo-controlled trial. Assessments were completed for cognition (days 0, 45, and 90), sleep (days 0 and 90), and mood (days 0 and 90) by using the Cognitive Drug Research (CDR) System

resultsQuality of working memory and spatial working memory accuracy improved after supplementation with 900 mg/day spearmint extract by 15% (p = 0.0469) and 9% (p = 0.0456), respectively, versus placebo. Subjects consuming 900 mg/day spearmint extract reported improvement in their ability to fall asleep, relative to subjects consuming placebo (p = 0.0046). Overall treatment effects were evident for vigor-activity (p = 0.0399), total mood disturbance (p = 0.0374), and alertness and behavior following wakefulness (p = 0.0415), with trends observed for improvements after spearmint supplementation relative to placebo.

conclusionsThese results suggest that the distinct spearmint extract may be a beneficial nutritional intervention for cognitive health in older subjects with AAMI.

Indexed as

CinnamatesCognitionDepsidesFemaleHumansMaleMemory DisordersMemory, Short-TermMentha spicataMiddle AgedPlant ExtractsPolyphenolsRosmarinic AcidSleepCinnamatesDepsidesPlant ExtractsPolyphenolsRosmarinic Acidpolyphenolsrosmarinic acidsleepspearmintworking memory

Identifiers

PMID29314866
PMCPMC5779242
OpenAlexW2783842886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.